Metraipolis › archive › dc_6fab497a07ea

Emodin promotes GSK-3β-mediated PD-L1 proteasomal degradation and enhances anti-tumor immunity in hepatocellular carcinoma — Europe PMC PMID:40804393

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40804393
DOI
10.1186/s13020-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-11-10T15:39:30.194Z
SHA-256 of the archived text
4c37e5991a4d7f6fe32bbaa480a498c97fae28b5cded94c6c204596f618c33e2
Stable URL of this page
https://metraipolis.com/documento/dc_6fab497a07ea

How to cite

Emodin promotes GSK-3β-mediated PD-L1 proteasomal degradation and enhances anti-tumor immunity in hepatocellular carcinoma — Europe PMC PMID:40804393 — Europe PMC (en), https://europepmc.org/article/MED/40804393 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6fab497a07ea (Metraipolis archive dc_6fab497a07ea, sha256 4c37e5991a4d7f6fe32bbaa480a498c97fae28b5cded94c6c204596f618c33e2)
BibTeX
@misc{dc6fab497a07ea,
  title = {Emodin promotes GSK-3β-mediated PD-L1 proteasomal degradation and enhances anti-tumor immunity in hepatocellular carcinoma — Europe PMC PMID:40804393},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40804393},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6fab497a07ea; sha256 4c37e5991a4d7f6fe32bbaa480a498c97fae28b5cded94c6c204596f618c33e2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40804393. Agents can read the archived copy with the MCP tool read_document.